Study of DISC-0974-201 for IBD and Anemia
Part of Blood & lymphatic, Digestive system clinical trials.
This trial tests a new medicine called DISC-0974-201 for people with inflammatory bowel disease and anemia. It aims to see if the drug can improve anemia symptoms and is for people with mild disease activity who have not responded well to standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have been diagnosed with Crohn's, ulcerative colitis, or IBD-unclassified (confirmed by endoscopy and biopsy).
- Your anemia is causing symptoms like fatigue, shortness of breath, or dizziness, and your hemoglobin is between 7 and 12 g/dL (women) or 7 and 13 g/dL (men).
- You have mild active IBD (not moderate or severe) and your ferritin level is at least 75 μg/L.
- You have not had IV iron, a blood transfusion, or an erythropoiesis-stimulating agent in the last 30 days, and you are not currently taking a JAK inhibitor.
- You are not pregnant or breastfeeding, and you agree to use effective contraception if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called DISC-0974 for people with myelofibrosis or certain types of MDS who have low red blood cell counts (anemia). The goal is to see if this treatment can help improve anemia and reduce the need for blood transfusions.
This trial tests a new treatment called CMTS0929 for people with inflammatory bowel disease (IBD), a condition that causes inflammation in the digestive tract. It aims to see if the treatment works and is safe.
This study tests a new investigational drug called PVT401 in healthy people. It is a first-in-human study to see how the drug is handled by the body and to check for any side effects.
This study is gathering information from people with active Crohn's disease or ulcerative colitis, and from people without IBD. Researchers will look at samples from the colon to learn more about these conditions.
This trial tests an experimental drug, HS-20106, to see if it can improve low red blood cell counts (anemia) for people with a certain type of bone marrow disorder called myelodysplastic syndromes (MDS), which is not high risk. It might be an option if you have not received certain prior treatments.
This trial looks at how immune cells change during severe IBD flare-ups. It aims to better understand inflammation and may lead to new ways to treat flares.
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.